ArticlePsychiatry and clinical psychopharmacology2026
The Therapeutic Effect of Methylphenidate Hydrochloride in Conjunction with Sensory Integration Training in Children with Attention Deficit Hyperactivity Disorder.
Article in Psychiatry and clinical psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Attention deficit hyperactivity disorder (ADHD) is a prevalent childhood disorder with existing treatment challenges, and research on the combined therapy of methylphenidate hydrochloride and sensory integration training for it is inconclusive. Thus, this study explored the clinical efficacy of this combined treatment in children with ADHD, finding it significantly improved relevant scores and reduced adverse reactions, suggesting its potential for wider use. Methods: From June 2022 to June 2023, a research sample of 102 individuals diagnosed with ADHD was recruited and allocated into 2 groups at an observation group (n=52) and a control group (n=50). Exclusively methylphenidate hydrochloride extended-release tablets were given to the control group as treatment, whereas the observation group underwent combined therapy with methylphenidate hydrochloride extended-release tablets and sensory integration training. The assessment and comparison of sensory integration and praxis tests, full-scale response control quotient, full-scale attention quotient, Conners' behavior rating scale, and adverse reactions during the treatment period were conducted prior to and following 2 treatment cycles in both the observation and control groups. Results: Prior to treatment, there were no remarkable variations ( Conclusion: To summarize, the utilization of methylphenidate hydrochloride alongside sensory integration training has demonstrated promising effectiveness in treating children diagnosed with ADHD and deserves broader implementation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.